A Gene Therapy Being Developed to Treat Batten Disease Has Been Granted Orphan Drug Status in Europe
Source: Pixabay

A Gene Therapy Being Developed to Treat Batten Disease Has Been Granted Orphan Drug Status in Europe

A gene therapy called ABO-202 that is being developed to treat Batten disease has just been granted Orphan Drug Designation by the European Medicines Agency (EMA), reports BioPortfolio. This follows…

Continue Reading A Gene Therapy Being Developed to Treat Batten Disease Has Been Granted Orphan Drug Status in Europe
A Treatment for Batten Disease Was Given Rare Pediatric Disease Designation from the FDA
source: pixabay.com

A Treatment for Batten Disease Was Given Rare Pediatric Disease Designation from the FDA

According to a story from pharmpro.com, the pharmaceutical company Abeona Therapeutics announced that it has been given Rare Pediatric Disease Designation for its ABO-202 program by the U.S. Food and…

Continue Reading A Treatment for Batten Disease Was Given Rare Pediatric Disease Designation from the FDA
An Experimental Drug for Batten Disease Just Got Orphan Drug Designation From The EMA
Source: Pixabay

An Experimental Drug for Batten Disease Just Got Orphan Drug Designation From The EMA

According to an article from kait8.com, the pharmaceutical company Polaryx announced that its experimental drug PLX-200 has received Orphan Drug Designation from the European Medicines Agency (EMA) for the treatment…

Continue Reading An Experimental Drug for Batten Disease Just Got Orphan Drug Designation From The EMA
A Girl From Colorado is Receiving An Experimental Treatment for Her Batten Disease
Photo courtesy of Julia Vitarello

A Girl From Colorado is Receiving An Experimental Treatment for Her Batten Disease

According to an article from Times-Call Regional News, a seven year old girl named Mila Makovec has just begun an experimental treatment for Batten disease. Originally from Boulder County, Colorado,…

Continue Reading A Girl From Colorado is Receiving An Experimental Treatment for Her Batten Disease

Editor’s Choice: IDF Sessions on CGD, IPF Progress and FDA Approval

Happy Friday Patient Worthians! You might notice that the headline has a lot of acronyms in it... ah, welcome to the rare disease world! We DO have answers for what all of that…

Continue Reading Editor’s Choice: IDF Sessions on CGD, IPF Progress and FDA Approval